Detalles de la búsqueda
1.
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Br J Cancer
; 130(8): 1249-1260, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361045
2.
Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.
EMBO J
; 39(6): e104013, 2020 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32009247
3.
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.
Gynecol Oncol
; 166(2): 334-343, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738917
4.
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival.
Histopathology
; 73(6): 1002-1012, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30007074
5.
Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC).
Cytokine
; 85: 157-64, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27371774
6.
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.
JCO Precis Oncol
; 8: e2300348, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38513168
7.
Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
J Proteome Res
; 12(9): 4056-63, 2013 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889230
8.
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients.
Cancers (Basel)
; 15(12)2023 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370765
9.
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium.
Oncogene
; 42(33): 2473-2484, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402882
10.
The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.
Int J Gynecol Cancer
; 22(3): 372-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22246403
11.
In Situ N-Glycosylation Signatures of Epithelial Ovarian Cancer Tissue as Defined by MALDI Mass Spectrometry Imaging.
Cancers (Basel)
; 14(4)2022 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35205768
12.
T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer.
Cancers (Basel)
; 14(17)2022 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077784
13.
Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial.
Ther Adv Med Oncol
; 14: 17588359221126149, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36172173
14.
An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.
BMC Cancer
; 11: 294, 2011 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21756326
15.
Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.
Cancers (Basel)
; 13(7)2021 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33806030
16.
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging.
Cancers (Basel)
; 12(8)2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32707805
17.
Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer.
Clin Cancer Res
; 26(1): 213-219, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527166
18.
EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM.
Mol Cancer Res
; 18(2): 278-286, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31704732
19.
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
J Natl Cancer Inst
; 112(12): 1190-1203, 2020 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32413141
20.
Incidence and Pattern of Spread of Lymph Node Metastasis in Patients With Low-grade Serous Ovarian Cancer.
Anticancer Res
; 39(10): 5617-5621, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570458